- Home
- CSTE vs CGTX Comparison
CSTE vs CGTX Comparison
Compare CSTE & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- CGTX
- Stock Information
- Founded
- CSTE 1987
- CGTX 2007
- Country
- CSTE Israel
- CGTX United States
- Employees
- CSTE N/A
- CGTX N/A
- Industry
- CSTE Building Materials
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- CSTE Industrials
- CGTX Health Care
- Exchange
- CSTE Nasdaq
- CGTX Nasdaq
- Market Cap
- CSTE 61.9M
- CGTX 53.4M
- IPO Year
- CSTE 2012
- CGTX 2021
- Fundamental
- Price
- CSTE $1.39
- CGTX $2.41
- Analyst Decision
- CSTE
- CGTX Strong Buy
- Analyst Count
- CSTE 0
- CGTX 3
- Target Price
- CSTE N/A
- CGTX $2.83
- AVG Volume (30 Days)
- CSTE 55.8K
- CGTX 12.4M
- Earning Date
- CSTE 08-06-2025
- CGTX 08-07-2025
- Dividend Yield
- CSTE N/A
- CGTX N/A
- EPS Growth
- CSTE N/A
- CGTX N/A
- EPS
- CSTE N/A
- CGTX N/A
- Revenue
- CSTE $406,178,000.00
- CGTX N/A
- Revenue This Year
- CSTE N/A
- CGTX N/A
- Revenue Next Year
- CSTE $5.61
- CGTX N/A
- P/E Ratio
- CSTE N/A
- CGTX N/A
- Revenue Growth
- CSTE N/A
- CGTX N/A
- 52 Week Low
- CSTE $1.35
- CGTX $0.22
- 52 Week High
- CSTE $5.04
- CGTX $3.83
- Technical
- Relative Strength Index (RSI)
- CSTE 34.55
- CGTX 61.15
- Support Level
- CSTE $1.35
- CGTX $2.26
- Resistance Level
- CSTE $1.47
- CGTX $2.67
- Average True Range (ATR)
- CSTE 0.08
- CGTX 0.40
- MACD
- CSTE 0.00
- CGTX -0.03
- Stochastic Oscillator
- CSTE 17.39
- CGTX 42.08
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.